United States· US:69448-016_472e3da5-bba8-1d0e-e063-6394a90af880
HERCESSI
A medicinal product containing trastuzumab-strf, registered in United States by Accord BioPharma Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TRASTUZUMAB-STRF
- Manufacturer
- Accord BioPharma Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1169448-016-11
- ndc1169448016111 VIAL, MULTI-DOSE in 1 CARTON (69448-016-11) / 20 mL in 1 VIAL, MULTI-DOSE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trastuzumab-strf in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomHerceptin 150mg powder for concentrate for solution for infusion vialsRoche Products Ltd
- FinlandDazublysCuraTeQ Biologics (Malta) Limited
- CzechiaDAZUBLYSCuraTeQ Biologics (Malta) Limited, Floriana
- BelgiumDazublys 150 mgCuraTeQ Biologics (Malta)
- SwedenDazublys 150 mg Pulver till koncentrat till infusionsvätska, lösningCuraTeQ Biologics (Malta) Limited
- PolandDazublysCuraTeQ Biologics s.r.o.
- IcelandDazublysCuraTeQ Biologics (Malta) Limited
- IrelandDazublys 150 mg powder for concentrate for solution for infusionCurateq Biologics s.r.o.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Dazublys, Herceptin
- Liechtenstein · Dazublys, Herceptin
- Norway · Dazublys, Herceptin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1721c3bb-747c-4611-8ef0-9a54c8c1d040 GET /v1/drugs/1721c3bb-747c-4611-8ef0-9a54c8c1d040?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "420",
"substance": "TRASTUZUMAB-STRF",
"productndc": "69448-016",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/20mL",
"application_number": "BLA761346",
"marketing_category": "BLA"
}See everything about trastuzumab-strf.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.